Bracco

Bracco Imaging is a global leader in diagnostic imaging, dedicated to improving people’s lives by shaping the future of prevention and precision medicine. With a strong passion for innovation, the company develops and provides a broad portfolio of pharmaceutical products for diagnostic imaging: contrast agents for X-ray, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI), as well microbubbles for Contrast Enhanced Ultrasound (CEUS), and Molecular Imaging through radioactive tracers and novel PET imaging agents, alongside specialized medical devices and related services. The company is committed to advancing diagnostic imaging by sharing knowledge to cultivate future thought leaders, linking today’s practice with tomorrow’s progress. Since 1927, Bracco Imaging has grown to more than 3,800 employees and now supports patients, healthcare professionals, and healthcare systems in over 100 countries.